In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14

PLoS One. 2014 Jun 23;9(6):e100665. doi: 10.1371/journal.pone.0100665. eCollection 2014.

Abstract

Human adenovirus type 55 (HAdV-B55) represents a re-emerging human pathogen, and this adenovirus has been reported to cause outbreaks of acute respiratory diseases among military trainees and in school populations around the world. HAdV-B55 has been revealed to have evolved from homologous recombination between human adenovirus type 14 (HAdV-B14) and type 11 (HAdV-B11), but it presents different clinical manifestations from parental virus HAdV-B11. In the present paper, we report the distinct biological features of HAdV-B55 in comparison with the parental viruses HAdV-B11 and HAdV-B14 in cell cultures. The results showed that HAdV-B55 replicated well in various cells, similar to HAdV-B11 and HAdV-B14, but that its processing had a slower and milder cytopathic effect in the early stages of infection. Viral fitness analysis showed that HAdV-B55 exhibited higher levels of replication in respiratory cells than did either of its parents. Cytotoxicity and apoptosis analyses in A549 cells indicated that HAdV-B55 was less cytotoxic than HAdV-B11 and HAdV-B14 were and induced milder apoptosis. Finally, thermal sensitivity analysis revealed that HAdV-B55 exhibited lower thermostability than did either HAdV-B11 or HAdV-B14, which may limit the transmission of HAdV-B55 in humans. Together, the findings described here expand current knowledge about this re-emerging recombinant HAdV, shedding light on the pathogenesis of HAdV-B55.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviruses, Human / growth & development
  • Adenoviruses, Human / pathogenicity
  • Adenoviruses, Human / physiology*
  • Apoptosis
  • Cell Line, Tumor
  • Cytopathogenic Effect, Viral
  • Hot Temperature
  • Humans
  • Kinetics

Grants and funding

This work was supported by the National Basic Research Project of China (Grant 2012CB518904). Cheng-Feng Qin was supported by the Beijing Nova Program of Science and Technology (Grant 2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.